Intravitreal Ranibizumab (Lucentis®) in the Treatment of Non-leaking Macular Cysts in Retinal Dystrophy
Condition(s):Retinal DystrophiesLast Updated:September 23, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Retinal DystrophiesLast Updated:September 23, 2019Completed
Condition(s):ObesityLast Updated:October 31, 2023Not yet recruiting
Condition(s):HypoxiaLast Updated:September 25, 2018Completed
Condition(s):Childhood GlaucomaLast Updated:September 27, 2019Completed
Condition(s):Glaucoma; Glaucoma Eye; Glaucoma, Open-AngleLast Updated:October 4, 2022Withdrawn
Condition(s):Altitude Sickness; Hypertension, PulmonaryLast Updated:October 19, 2016Completed
Condition(s):GlaucomaLast Updated:September 11, 2019Completed
Condition(s):X-linked Retinoschisis; XLRSLast Updated:November 17, 2017Completed
Condition(s):Retinal DegenerationsLast Updated:October 29, 2021Completed
Condition(s):Primary Open Angle Glaucoma; Ocular HypertensionLast Updated:January 10, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.